AI Insight: Xylem Inc. trades 28.6% below a high-confidence fair value of $143.25, indicating undervaluation with strong upside potential. Financial health shows solid liquidity and leverage but weak growth, while Monte Carlo analysis reveals high volatility and a 44.4% downside risk below current price. Valuation consensus supports a positive risk/reward despite growth constraints.